Raymond James Maintains Outperform on PLx Pharma, Lowers Price Target to $10

Raymond James analyst Elliot Wilbur maintains PLx Pharma (NASDAQ:PLXP) with a Outperform and lowers the price target from $12 to $10.

Raymond James analyst Elliot Wilbur maintains PLx Pharma (NASDAQ:PLXP) with a Outperform and lowers the price target from $12 to $10.

Total
0
Shares
Related Posts